The ProDGNE consortium is pleased to invite you to the ProDGNE Kick-Off Webinar, which will be on the 3rd of June at 6:00pm:
https://bit.ly/3oAw2DR

 

In this webinar we will present ProDGNE, a 3 year transnational pre-clinical research project which brings together patients and researchers from Europe and Canada to develop an innovative therapeutic compound to treat GNE Myopathy (GNEM), a rare genetic muscle disease affecting young adults.

The project ProDGNE is coordinated by Paula Videira, leader of the Glycoimmunology Lab.

 

Speakers:

- Fabrizio Pertusati, School of Pharmacy and Pharmaceutical Sciences, Cardiff University, UK
- Hanns Lochmüller, University of Ottawa Faculty of Medicine and The Ottawa Hospital Department of Medicine, Canada
- Michela Onali, Gli Equilibristi HIBM, Italy
- Paula Videira, Faculdade de Ciências e Tecnologia at Universidade NOVA de Lisboa, Portugal
- Pierluigi Caboni, Department of Life and Environmental Sciences, University of Cagliari, Italy
- Rüdiger Horstkörte, Medical Faculty, Martin-Luther University Halle-Wittenberg, Germany

ProDGNE is funded in the framework of the European Joint Programme on Rare Diseases (EJP RD) Joint Transnational Call 2020 "Pre-Clinical Research to Develop Effective Therapies for Rare Diseases" and has received funding from the European Union's Horizon 2020 research and innovation programme under the EJP RD COFUND-EJP N 825575

 

For more info about ProDGNE visit: sites.fct.unl.pt/prodgne